Literature DB >> 17906914

Establishing an inpatient anticoagulation service: a step by step review.

John Viercinski1, Lynda Thomson, Joseph Wilson, Geno J Merli.   

Abstract

Inpatient anticoagulation services can reduce medication errors, reduce hospital costs, and improve patient care. However, before a hospital establishes an inpatient anticoagulation service, it is important to conduct a thoughtful, systematic review of the institution. Two factors that can determine the need for an inpatient anticoagulation service are the number of adverse drug events and the extent of medical-legal liability at the institution. Establishing an inpatient service that reduces these problems can justify the cost of the program. In addition to these factors, the institution's infrastructure and the scope of services to be provided should be evaluated, and parameters should be created to measure the clinical and financial impact of the inpatient anticoagulation service. Numerous publications in the literature have supported the need and positive impact of inpatient anticoagulation services on hospital costs and patient care. The size and scope of the service should be based upon the needs, experiences and resources of a specific institution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906914     DOI: 10.1007/s11239-007-0111-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  8 in total

1.  Medication errors associated with anticoagulant therapy in the hospital.

Authors:  John Fanikos; Carl Stapinski; Sophia Koo; Nils Kucher; Kanella Tsilimingras; Samuel Z Goldhaber
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

2.  Impact of smart infusion technology on administration of anticoagulants (unfractionated Heparin, Argatroban, Lepirudin, and Bivalirudin).

Authors:  John Fanikos; Karen Fiumara; Steve Baroletti; Carol Luppi; Catherine Saniuk; Amar Mehta; Jon Silverman; Samuel Z Goldhaber
Journal:  Am J Cardiol       Date:  2007-02-15       Impact factor: 2.778

3.  Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.

Authors:  W E Dager; J M Branch; J H King; R H White; R S Quan; N A Musallam; T E Albertson
Journal:  Ann Pharmacother       Date:  2000-05       Impact factor: 3.154

4.  Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis.

Authors:  Elaine M Hylek; Susan Regan; Lori E Henault; Margaret Gardner; Andrew T Chan; Daniel E Singer; Michael J Barry
Journal:  Arch Intern Med       Date:  2003-03-10

5.  Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Authors:  D W Bates; D J Cullen; N Laird; L A Petersen; S D Small; D Servi; G Laffel; B J Sweitzer; B F Shea; R Hallisey
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

6.  Analysis of medication-related malpractice claims: causes, preventability, and costs.

Authors:  Jeffrey M Rothschild; Frank A Federico; Tejal K Gandhi; Rainu Kaushal; Deborah H Williams; David W Bates
Journal:  Arch Intern Med       Date:  2002-11-25

7.  Therapeutic heparin monitoring service in a small community hospital.

Authors:  S J Pawloski; P L Kersh
Journal:  Hosp Pharm       Date:  1992-08

8.  Systems analysis of adverse drug events. ADE Prevention Study Group.

Authors:  L L Leape; D W Bates; D J Cullen; J Cooper; H J Demonaco; T Gallivan; R Hallisey; J Ives; N Laird; G Laffel
Journal:  JAMA       Date:  1995-07-05       Impact factor: 56.272

  8 in total
  1 in total

1.  Challenges and benefits of an inpatient anticoagulation service: one hospital's experience.

Authors:  Allison Burnett; Richard D'Angio; Laura E Earl; David Garcia
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.